Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.coph.2016.01.002 http://scihub22266oqcxt.onion/10.1016/j.coph.2016.01.002 C4808470!4808470!26828626     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Opin+Pharmacol 2016 ; 27 (ä): 8-12 Nephropedia Template TP {{tp|p=26828626|t=2016. Gut Microbiome as a Novel Cardiovascular Therapeutic Target |pdf=|usr=}}{{26828626}} gab.com Text Gut Microbiome as a Novel Cardiovascular Therapeutic Target JO: Curr Opin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=26828626 #FOAvip Over the last two decades, our understanding of gut microbiotal composition and its association with intra- and extra-intestinal diseases including risk factors of cardiovascular disease (CVD) namely metabolic syndrome and atherosclerosis, have been increased exponentially. A pertinent question which often arises in researchers? community is on how to manipulate the gut microbial ecology to ?cure? the cardiovascular risk factors. Accordingly, in this review we summarized the potential strategies, based on our current knowledge on gut microbiota in modulating CVD, how gut microbiota can be therapeutically exploited by targeting their metabolic activity to alleviate the risk factors of CVD. Twit Text FOAVip Gut Microbiome as a Novel Cardiovascular Therapeutic Target ????Curr Opin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=26828626 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26828626 #FOAvip English Wikipedia <ref>{{Cite pmid|26828626}}</ref> Gut Microbiome as a Novel Cardiovascular Therapeutic Target #MMPMID26828626 Singh V; Yeoh BS; Vijay-Kumar M Curr Opin Pharmacol 2016[Apr]; 27 (ä): 8-12 PMID26828626show ga Over the last two decades, our understanding of gut microbiotal composition and its association with intra- and extra-intestinal diseases including risk factors of cardiovascular disease (CVD) namely metabolic syndrome and atherosclerosis, have been increased exponentially. A pertinent question which often arises in researchers? community is on how to manipulate the gut microbial ecology to ?cure? the cardiovascular risk factors. Accordingly, in this review we summarized the potential strategies, based on our current knowledge on gut microbiota in modulating CVD, how gut microbiota can be therapeutically exploited by targeting their metabolic activity to alleviate the risk factors of CVD. äGut Microbiome as a Novel Cardiovascular Therapeutic Target (epmc).pdf DeepDyve Pubget Overpricing